Neuromyelitis optica IgG and related clinical features of patients with neuromyelitis optica

National Medical Journal of China

Volumn 90, Issue 35, 2010, Pages 2477-2480

  You, Xiao Fan ^a   Ye, Jing ^a   Li, Cun Jiang ^a   Liao, Zhang Yuan ^a   Sun, Hui ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Fluorescent antibody technique, indirect; Immunoglobulin G; Multiple sclerosis; Neuromyelitis optica

Indexed keywords

IMMUNOGLOBULIN G; BIOLOGICAL MARKER;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISABILITY SEVERITY; DISEASE COURSE; DISEASE MARKER; HUMAN; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; SPINAL CORD LESION; ADOLESCENT; ADULT; BLOOD; CASE CONTROL STUDY; CHILD; FEMALE; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84871434437     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.35.009     Document Type: Article

References (21)

1. Lennon V A, Wingerchuk D M, Kryzer T J, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet, 2004, 364: 2106-2112.
2. Mandler R N. Neuromyelitis optica-Devic's syndrome, update. Autoimmun Rev, 2006, 5: 537-543.
3. Jacob A, Matiello M, Wingerchuk D M, et al. Neuromyelitis optica: changing concepts. J Neuroimmunol, 2007, 187: 126-138.
4. Wingerchuk D M, Lennon V A, Pittock S J, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology, 2006, 66: 1485-1489.
5. Lennon V A, Kryzer T J, Pittock S J, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med, 2005, 202: 473-477.
6. Takahashi T, Fujihara K, Nakashima I, et al. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med, 2006, 210: 307-313.
7. Jarius S, Franciotta D, Bergamaschi R, et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology, 2007, 68: 1076-1077.
8. Wingerchuk D M, Hogancamp W F, O'Brien P C, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology, 1999, 53: 1107-1114.
9. Polman C H, Reingold S C, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 Revisions to the "McDonald Criteria". Ann Neurol, 2005, 58: 840-846.
10. Paul F, Jarius S, Aktas O, et al. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med, 2007, 4: e133.
11. Hayakawa S, Mori M, Okuta A, et al. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol, 2008, 196: 181-187.
12. Cabrera-Gomez J A, Bonnan M, Gonzalez-Quevedo A, et al. Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies. Mult Scler, 2009, 15: 828-833.
13. Waters P, Vincent A. Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MSJ, 2008, 15: 99-105.
14. Chan K H, Ramsden D B, Yu Y L, et al. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese. Eur J Neurol, 2009, 16: 310-316.
15. Marignier R, De Seze J, Vukusic S, et al. NMO-IgG and Devic's neuromyelitis optica: a French experience. Mult Scler, 2008, 14: 440-445.
16. Takahashi T, Fujihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody litre. Brain, 2007, 130: 1235-1243.
17. Nakashima I, Fujihara K, Miyazawa I, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry, 2006, 77: 1073-1075.
18. Pittock S J, Lennon V A, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol, 2006, 63: 390-396.
19. Pittock S J, Weinshenker B G, Lucchinetti C F, et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol, 2006, 63: 964-968.
20. Li Y, Xie P, Lv F, et al. Brain magnetic resonance imaging abnormalities in neuromyelitis optica. Acta Neurol Scand, 2008, 118: 218-225.
21. Roemer S F, Parisi J E, Lennon V A, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain, 2007, 130: 1194-1205.